X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3687) 3687
Publication (255) 255
Government Document (48) 48
Dissertation (36) 36
Book Review (22) 22
Book Chapter (8) 8
Conference Proceeding (8) 8
Book / eBook (1) 1
Journal / eJournal (1) 1
Magazine Article (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2621) 2621
her-2/neu (2176) 2176
female (2091) 2091
oncology (1822) 1822
breast cancer (1254) 1254
immunohistochemistry (1130) 1130
middle aged (1088) 1088
index medicus (979) 979
aged (896) 896
cancer (879) 879
expression (862) 862
adult (859) 859
prognosis (812) 812
breast neoplasms - pathology (776) 776
receptor, erbb-2 - metabolism (737) 737
gene amplification (676) 676
trastuzumab (647) 647
overexpression (641) 641
receptor, erbb-2 - genetics (633) 633
carcinoma (632) 632
pathology (609) 609
in-situ hybridization (579) 579
breast neoplasms - metabolism (560) 560
animals (559) 559
breast neoplasms - genetics (558) 558
amplification (552) 552
her2 (521) 521
breast-cancer (520) 520
male (492) 492
aged, 80 and over (487) 487
mice (421) 421
in situ hybridization, fluorescence (416) 416
oncogene (413) 413
survival (408) 408
chemotherapy (407) 407
breast neoplasms - drug therapy (368) 368
receptor, erbb-2 - analysis (361) 361
therapy (358) 358
tumors (340) 340
growth-factor receptor (324) 324
monoclonal-antibody (318) 318
gene expression regulation, neoplastic (314) 314
c-erbb-2 (311) 311
receptor, erbb-2 - biosynthesis (298) 298
neoplasm staging (293) 293
research (291) 291
receptor, erbb-2 - immunology (290) 290
ovarian-cancer (277) 277
protein (266) 266
gene expression (265) 265
genes, erbb-2 (262) 262
cell biology (261) 261
antibodies, monoclonal, humanized (260) 260
cell line, tumor (259) 259
neu oncogene (256) 256
biomarkers, tumor - analysis (248) 248
immunology (243) 243
p53 (241) 241
antineoplastic agents - therapeutic use (234) 234
prognostic-significance (231) 231
fish (228) 228
cells (225) 225
metastasis (224) 224
retrospective studies (222) 222
medicine & public health (219) 219
analysis (216) 216
care and treatment (216) 216
biomarkers, tumor - metabolism (215) 215
receptor (209) 209
obstetrics & gynecology (208) 208
her-2 neu oncogene (204) 204
medicine, research & experimental (204) 204
treatment outcome (204) 204
neu (200) 200
genetic aspects (199) 199
epidermal growth factor (194) 194
her-2/neu gene amplification (193) 193
antibodies, monoclonal - therapeutic use (186) 186
survival analysis (186) 186
her-2 (185) 185
biochemistry & molecular biology (184) 184
disease-free survival (184) 184
gene (184) 184
breast neoplasms - diagnosis (182) 182
fluorescence in situ hybridization (180) 180
proteins (180) 180
skin and connective tissue diseases (180) 180
predictive value of tests (179) 179
her2/neu (177) 177
protein expression (177) 177
immunotherapy (175) 175
tumor cells, cultured (175) 175
carcinomas (173) 173
survival rate (172) 172
estrogen-receptor (171) 171
lymphatic metastasis (168) 168
adjuvant chemotherapy (166) 166
metastatic breast-cancer (162) 162
adenocarcinoma (160) 160
antineoplastic combined chemotherapy protocols - therapeutic use (158) 158
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3630) 3630
German (28) 28
Spanish (23) 23
Chinese (22) 22
French (21) 21
Korean (21) 21
Polish (8) 8
Japanese (6) 6
Turkish (6) 6
Persian (4) 4
Italian (3) 3
Portuguese (3) 3
Arabic (1) 1
Croatian (1) 1
Czech (1) 1
Hungarian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Original Article - FISH for HER-2/neu in breast cancer: Standardization makes the difference, 10/2004
CONTEXT: Overexpression of HER-2/neu oncogene in breast cancer patients is correlated with disease free survival (DFS) and overall survival (OS). The most... 
Breast cancer, HER-2/neu, Amplification, IHC, FISH, DCIS, Pathvysion™, Validation. cn04029 | Botany
Journal
European Journal of Surgical Oncology, ISSN 0748-7983, 11/2019, Volume 45, Issue 11, pp. 2022 - 2025
Her-2/neu is one of the most important molecular markers of breast cancer. Overexpression of Her-2/neu as evaluated by immunohistochemistry is necessary in the... 
Breast cancer | Her-2/neu overexpression | Histological grade | Age
Journal Article
Journal of Postgraduate Medical Institute, ISSN 1013-5472, 10/2018, Volume 32, Issue 4, pp. 359 - 363
Journal Article
Journal Article
Asian Pacific Journal of Cancer Prevention, ISSN 1513-7368, 2015, Volume 16, Issue 17, pp. 7695 - 7700
Journal Article
CLINICAL CANCER RESEARCH, ISSN 1078-0432, 07/2019, Volume 25, Issue 14, pp. 4248 - 4254
Purpose: In phase I/II studies, nelipepimutS (NPS) plus GMCSF vaccine was well tolerated and effectively raised HER2specific immunity in patients with breast... 
IMMUNIZATION | HER2/NEU E75 VACCINE | GROUP-STUDY I-01 | THERAPY | TRASTUZUMAB | ONCOLOGY | GUIDELINES | IMMUNE-RELATED RESPONSE | HER-2/NEU | AMERICAN SOCIETY | PEPTIDE
Journal Article
CLINICAL CANCER RESEARCH, ISSN 1078-0432, 11/2017, Volume 23, Issue 21, pp. 6616 - 6628
Purpose: Camelid single-domain antibody-fragments (sdAb) have beneficial pharmacokinetic properties, and those targeted to HER2 can be used for imaging of... 
HUMAN-BREAST-CANCER | ONCOLOGY | NANOBODIES | HER2-TARGETED THERAPIES | TARGETED RADIONUCLIDE THERAPY | RESISTANCE | RECEPTOR | N-SUCCINIMIDYL | HER-2 NEU ONCOGENE | CELL-LINES | TRASTUZUMAB EMTANSINE
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 03/2009, Volume 27, Issue 8, pp. 1323 - 1333
Journal Article
CANCER RESEARCH, ISSN 0008-5472, 10/2018, Volume 78, Issue 19, pp. 5706 - 5717
IFN gamma is an attractive target for imaging active antitumor immunity due to its function in the T-cell signaling axis. Here, we test an IFN gamma immuno-PET... 
BIOMARKERS | IMMUNITY | INTERFERON-GAMMA | ONCOLOGY | INFILTRATING LYMPHOCYTES | HER-2/NEU | CANCER-IMMUNOTHERAPY | BLOCKADE | EXPRESSION | DNA VACCINATION | TRANSGENIC MICE
Journal Article
11/2010
Dendritic cells (DCs) are promising mediators of anti-tumour immune responses. Unfortunately, a major hindrance to the development of highly effective DC... 
lentivector | dendritic cells | 0982 | cancer immunotherapy | gene therapy | HER-2/neu | 0307 | dendritic cell longevity | antigen n-glycosylation | lentivirus
Dissertation
Scientific reports, ISSN 2045-2322, 12/2019, Volume 9, Issue 1, pp. 542 - 12
Microcalcifications are vital mammographic indicators contributing to the early detection of up to 50% of non-palpable tumours and may also be valuable as... 
PHOSPHATE | MAMMOGRAPHIC CALCIFICATIONS | OSTEOPONTIN | HER-2/NEU OVEREXPRESSION | PROGNOSTIC-FACTORS | MULTIDISCIPLINARY SCIENCES | VASCULAR CALCIFICATION | CANCER | CARCINOMA | MICROCALCIFICATIONS | FEATURES
Journal Article